Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.24.1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

Note 16 - Income Taxes

Income tax expense (recoveries) for the years ended December 31, 2023 and 2022 consisted of the following:

 

 

 

2023

 

 

2022

 

Current income tax expense

 

 

 

 

 

 

Federal

 

$

 

15,769

 

 

$

 

16,035

 

State

 

 

 

4,362

 

 

 

 

2,438

 

Total current income tax expense

 

 

 

20,131

 

 

 

 

18,473

 

Deferred income tax recoveries

 

 

 

 

 

 

 

 

Federal

 

 

 

(2,787

)

 

 

 

(7,360

)

State

 

 

 

(644

)

 

 

 

(422

)

Total deferred income tax recoveries

 

 

 

(3,431

)

 

 

 

(7,782

)

Income tax expense

 

$

 

16,700

 

 

$

 

10,691

 

 

Income tax expense differed from the amount computed by applying the federal statutory tax rate of 21.0% for the years ended December 31, 2023 and 2022 due to the following:

 

 

 

2023

 

 

2022

 

Pretax loss at federal statutory rate

 

$

 

(12,583

)

 

$

 

(92,128

)

State income tax expense, net of federal expense

 

 

 

(1,249

)

 

 

 

(512

)

Non-deductible items

 

 

 

16,443

 

 

 

 

109,980

 

True-up of income taxes payable

 

 

 

(104

)

 

 

 

(398

)

Foreign deferred taxes with no benefit recognized

 

 

 

 

 

 

 

(24,663

)

Other items

 

 

 

(40

)

 

 

 

(31

)

Change in valuation allowance

 

 

 

14,233

 

 

 

 

18,443

 

Income tax expense

 

$

 

16,700

 

 

$

 

10,691

 

 

The tax effects of temporary differences that give rise to significant portions of the deferred income tax assets and liabilities as of December 31, 2023 and 2022 are presented below:

 

 

 

2023

 

 

2022

 

Deferred income tax assets:

 

 

 

 

 

 

 

Net operating loss carryforwards

 

$

 

47,431

 

 

$

 

45,761

 

Interest expense carryforwards

 

 

 

37,014

 

 

 

 

32,440

 

Stock based compensation

 

 

 

16,209

 

 

 

 

14,927

 

Intangible assets

 

 

 

2,916

 

 

 

 

3,901

 

Property, plant and equipment

 

 

 

5,391

 

 

 

 

4,898

 

Inventories

 

 

 

139

 

 

 

 

309

 

Other items

 

 

 

638

 

 

 

 

597

 

 

 

 

 

109,738

 

 

 

 

102,833

 

Valuation allowance

 

 

 

(105,257

)

 

 

 

(98,519

)

Deferred income tax assets

 

$

 

4,481

 

 

$

 

4,314

 

Deferred income tax liabilities:

 

 

 

 

 

 

 

 

Intangibles resulting from acquisitions

 

 

 

(24,893

)

 

 

 

(28,129

)

Deferred income tax liabilities

 

 

 

(24,893

)

 

 

 

(28,129

)

Net deferred income tax liabilities

 

$

 

(20,412

)

 

$

 

(23,815

)

 

The Company is subject to taxation in Canada and the United States. As the Company operates in state-level legal cannabis industry within the United States, the Company is subject to the limits of Internal Revenue Code (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E and a higher effective tax rate than most industries.

As of December 31, 2023, the Company has Canadian non-capital loss carryforwards of $124.3 million available to offset future income which will expire in the years 2025 through 2042. As of December 31, 2023, the Company has federal net operating loss carryforwards of approximately $170.1 million available to offset future income of which $11.0 million will expire in the years 2035 through 2037 while the remaining $159.1 million are indefinite lived. Of the $170.1 million of federal net operating loss carryforwards, approximately all amounts are subject to IRC Section 382 limitations. Additionally, the Company has net operating loss carryforwards for state purposes aggregating $179.2 million as of December 31, 2023, of which $173.9 million will expire in the year 2028 through 2043 while the remaining $5.3 million have indefinite lives. Of the $173.9 million of state net operating loss carryforwards, approximately all amounts are subject to IRC Section 382 limitations. The increase in the valuation allowance was primarily due to management’s conclusion that the deferred tax assets of non-cultivator entities are more likely than not to not be realized as well as recording of a valuation allowance against certain net operating losses and Section 163(j) carryforwards generated during the year.

In general, under Section 382 of the U.S. Internal Revenue Code of 1986, as amended, a corporation that undergoes an “ownership change” is subject to limitations on its ability to utilize its pre-change net operating loss carryforwards (“NOLs”) to offset future taxable income. Similarly, where control of a corporation has been acquired by a person or group of persons, subsection 111(5) of the Income Tax Act (Canada), and equivalent provincial income tax legislation restrict the corporation’s ability to carry forward non-capital losses from preceding taxation years. The Company concluded that the Recapitalization Transaction which closed on June 24, 2022 did not qualify as an acquisition of control for Canadian tax purposes; therefore, the Company’s existing Canadian non-capital losses are unlimited and continue to have a full valuation allowance set against its deferred tax assets. The U.S. NOLs will be subject to a substantial annual limitation arising from the Company’s ownership changes. As a result, a full valuation allowance has been recorded by the Company on these deferred tax assets as well as any Section 163(j) interest limitation deduction carryforwards. The Section 382 limitation is increased by recognized built-in gain (“RBIG”) in the five year period following the change date to the extent that the value of the loss corporation’s assets exceed the tax basis of these assets. Under the Section 338 approach, assets are treated as generating RBIG even if these assets are not disposed of during the five year recognition period. The Company is in the process of reviewing the tax basis of their fixed assets so it can compare it to the deemed selling price under Section 382 of the code. The Company is expecting that this calculation may result in a RBIG that would increase the Section 382 limitation available over the next five years.

The Company files income tax returns in Canada, Luxembourg, United States and various state and local tax jurisdictions. The Company’s income tax years open to examination for Canadian federal income taxes are from 2013 through 2020, for United States federal income taxes are from 2019 through 2022, and for state and local income taxes vary from 2019 to 2022. The Company is not aware of any ongoing audits that would materially impact the consolidated financial statements. Net operating losses arising prior to these years are also open to examination if and when utilized. The Company is in active collection procedures with the Internal Revenue Services and is negotiating payment agreements with the support of an external advisor.

The Internal Revenue Service filed Notices of Federal Tax Liens against certain subsidiaries of the Company in the aggregate amount of approximately $16.4 million and $24.5 million for the years ended December 31, 2020 and 2021, respectively. The Company is actively working to resolve these matters with the Internal Revenue Service.